Carotenoids in human nutrition and health

Archives of Biochemistry and Biophysics

Volumn 652, Issue , 2018, Pages 18-26

  Eggersdorfer, Manfred ^a,b   Wyss, Adrian ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Age Related Eye Disease Study; age related macular degeneration; AMD; AREDS; ATBC; Cancer prevention; CARET; Carotenoids; CI; Cognitive function; confidence interval; contrast sensitivity; CS; Eye health; glare tolerance; GT; hazard ratio; HDL; Healthy ageing; high density lipoprotein; HR; L; LDL; Linxian; Linxian General Population Trial; low density lipoprotein; lutein; Macular Pigment Optical Density; MPOD; odds ratio; OR; photophobia; photostress recovery; PHS; Physicians' Health Study; PL; placebo; PP; PRT; relative risk; RR; SD; standard deviation; Telephone Interview Cognitive Status; TICS; Z; zeaxanthin; Tocopherol, Carotene Cancer Prevention Study; Carotene And Retinol Efficacy Trial

Indexed keywords

CAROTENOID; RETINOL; ANTIOXIDANT;

BODY WEIGHT CONTROL; BONE CHARACTERISTICS AND FUNCTIONS; CANCER PREVENTION; CARDIOVASCULAR FUNCTION; DIET SUPPLEMENTATION; EYE HEALTH; HEALTH; HUMAN; IMMUNE RESPONSE; INFANT NUTRITION; NUTRITION; PRIORITY JOURNAL; REVIEW; CATARACT; CHEMISTRY; DIETARY SUPPLEMENT; FRUIT; MACULAR DEGENERATION; VEGETABLE;

ANTIOXIDANTS; CAROTENOIDS; CATARACT; DIETARY SUPPLEMENTS; FRUIT; HUMANS; MACULAR DEGENERATION; VEGETABLES;

EID: 85048538492     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2018.06.001     Document Type: Review

References (92)

1. GBD, 2016 Causes of Death Collaborators, Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2016), 1151–1210.
2. GBD, 2016 Risk Factors Collaborators, Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1345–1422.
3. World Health Organization, The world health report 2002-Reducing risks, promoting healthy life. http://www.who.int/whr/2002/en/, 2002. (Accessed 17 October 2017)
4. Rockström, J., Stordalen, G.A., Horton, R., Acting in the anthropocene: the eat-lancet commission. Lancet 387 (2016), 2364–2365.
5. Milani, A., Basirnejad, M., Shahbazi, S., Bolhassani, A., Carotenoids: biochemistry, pharmacology and treatment. Br. J. Pharmacol. 174 (2017), 1290–1324.
6. Johnson, E.J., A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am. J. Clin. Nutr., 96, 2012 1161S-1165S.
7. Khoo, H.E., Prasad, K.N., Kong, K.W., Jiang, Y., Ismail, A., Carotenoids and their isomers: color pigments in fruits and vegetables. Molecules 16 (2011), 1710–1738.
8. Zimmer, J.P., Hammond, B.R. Jr., Possible influences of lutein and zeaxanthin on the developing retina. Clin. Ophthalmol. 1 (2007), 25–35.
9. Al-Delaimy, W.K., van Kappel, A.L., Ferrari, P., Slimani, N., Steghens, J.P., Bingham, S., Johansson, I., Wallström, P., Overvad, K., Tjønneland, A., Key, T.J., Welch AA, A.A., Bueno-de-Mesquita, H.B., Peeters, P.H., Boeing, H., Linseisen, J., Clavel-Chapelon, F., Guibout, C., Navarro, C., Quirós, J.R., Palli, D., Celentano, E., Trichopoulou, A., Benetou, V., Kaaks, R., Riboli, E., Plasma levels of six carotenoids in nine european countries: report from the european prospective investigation into cancer and nutrition (EPIC). Publ. Health Nutr. 7 (2004), 713–722.
10. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. 2000, Institute of Medicine.
11. Age-Related Eye Disease Study 2 Research Group, Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. J. Am. Med. Assoc. 309 (2013), 2005–2015.
12. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 132 (2014), 142–149.
13. Walk, A.M., Khan, N.A., Barnett SM, S.M., Raine, L.B., Kramer, A.F., Cohen, N.J., Moulton, C.J., Renzi-Hammond, L.M., Hammond, B.R., Hillman, C.H., From neuro-pigments to neural efficiency: the relationship between retinal carotenoids and behavioral and neuroelectric indices of cognitive control in childhood. Int. J. Psychophysiol. 118 (2017), 1–8.
14. Grodstein, F., Kang, J.H., Glynn, R.J., Cook, N.R., Gaziano JM, J.M., A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch. Intern. Med. 167 (2007), 2184–2190.
15. Johnson, E.J., McDonald, K., Caldarella, S.M., Chung, H.Y., Troen, A.M., Snodderly, D.M., Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr. Neurosci. 11 (2008), 75–83.
16. Cheng, H.M., Koutsidis, G., Lodge, J.K., Ashor, A.W., Siervo, M., Lara, J., Lycopene and tomato and risk of cardiovascular diseases: a systematic review and meta-analysis of epidemiological evidence. Crit. Rev. Food Sci. Nutr. 11 (2017), 1–18.
17. Wan, L., Tan, H.L., Thomas-Ahner, J.M., Pearl, D.K., Erdman, J.W. Jr., Moran, N.E., Clinton, S.K., Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis. Canc. Prev. Res. 7:12 (2014), 1228–1239.
18. Stahl, W., Sies, H., β-Carotene and other carotenoids in protection from sunlight. Am. J. Clin. Nutr., 96, 2012 1179S-1184S.
19. Köpcke, W., Krutmann, J., Protection from sunburn with beta-Carotene - a meta-analysis. Photochem. Photobiol. 84 (2008), 284–288.
20. Heinrich, U., Gartner, C., Wiebusch, M., Eichler, O., Sies, H., Tronnier, H., Stahl, W., Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J. Nutr. 133 (2003), 98–101.
21. Stahl, W., Heinrich, U., Jungmann, H., Sies, H., Tronnier, H., Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr. 71 (2000), 795–798.
22. Mínguez-Alarcón, L., Mendiola, J., López-Espín, J.J., Sarabia-Cos, L., Vivero-Salmerón, G., Vioque, J., Navarrete-Muñoz, E.M., Torres-Cantero, A.M., Dietary intake of antioxidant nutrients is associated with semen quality in young university students. Hum. Reprod. 27:9 (2012), 2807–2814.
23. Jonasson, L., Wikby, A., Olsson, A.G., Low serum beta-carotene reflects immune action in patients with coronary artery disease. Nutr. Metabol. Cardiovasc. Dis. 13 (2003), 120–125.
24. Palmer, A.C., West, K.P. Jr., Dalmiya, N., Schultink, W., The use and interpretation of serum retinol distributions in evaluating the public health impact of vitamin A programmes. Publ. Health Nutr. 15 (2012), 1201–1215.
25. Uchiyama, S., Yamaguchi, M., β-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1cells. Int. J. Mol. Med. 15 (2005), 675–681.
26. Sharoni, Y., Linnewiel-Hermoni, K., Zango, G., Khanin, M., Salman, H., Veprik, A., Danilenko, M., Levy, J., The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention. Am. J. Clin. Nutr., 96(5), 2012 1173S-8S.
27. Fiedor, J., Burda, K., Potential role of carotenoids as antioxidants in human health and disease. Nutrients 6 (2014), 466–488.
28. Gurmu, F., Hussein, S., Laing, M., The potential of orange-fleshed sweet potato to prevent vitamin A deficiency in Africa. Int. J. Vitam. Nutr. Res. 84 (2014), 65–78.
29. Barker, F.M. 2nd, Snodderly, D.M., Johnson, E.J., Schalch, W., Koepcke, W., Gerss, J., Neuringer, M., Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest. Ophthalmol. Vis. Sci. 52 (2011), 3934–3942.
30. Tanaka, T., Shnimizu, M., Moriwaki, H., Cancer chemoprevention by carotenoids. Molecules 17 (2012), 3202–3242.
31. Iwamoto, T., Hosoda, K., Hirano, R., Kurata, H., Matsumoto, A., Miki, W., Kamiyama, M., Itakura, H., Yamamoto, S., Kondo, K., Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atherosclerosis Thromb. 7 (2000), 216–222.
32. Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., Tada, N., Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 209 (2010), 520–523.
33. Weber, D., Grune, T., The contribution of beta-carotene to vitamin A supply of humans. Mol. Nutr. Food Res. 56:2 (2012), 251–258.
34. von Lintig, J., Provitamin A metabolism and functions in mammalian biology. Am. J. Clin. Nutr., 96, 2012 1234S-1244S.
35. Bernstein, P.S., Li, B., Vachali, P.P., Gorusupudi, A., Shyam, R., Henriksen, B.S., Nolan, J.M., Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog. Retin. Eye Res. 50 (2016), 34–66.
36. Bone, R.A., Landrum, J.T., Fernandez, L., Tarsis, S.L., Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest. Ophthalmol. Vis. Sci. 29 (1988), 843–849.
37. Feeney, J., Finucane, C., Savva, G.M., Cronin, H., Beatty, S., Nolan, J.M., Kenny, R.A., Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol. Aging 34 (2013), 2449–2456.
38. Hammond, B.R., Fletcher, L.M., Roos, F., Wittwer, J., Schalch, W., A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Invest. Ophthalmol. Vis. Sci. 55:12 (2014), 8583–8589, 10.1167/iovs.14-15573.
39. Yao, Y., Qiu, Q.H., Wu, X.W., Cai, Z.Y., Xu, S., Liang, X.Q., Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study. Nutrition 29 (2013), 958–964.
40. Loughman, J., Nolan, J.M., Howard, A.N., Connolly, E., Meagher, K., Beatty, S., The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest. Ophthalmol. Vis. Sci. 53 (2012), 7871–7880.
41. Nolan, J.M., Loughman, J., Akkali, M.C., Stack, J., Scanlon, G., Davison, P., Beatty, S., The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vis. Res. 51 (2011), 459–469.
42. Richer, S.P., Stiles, W., Graham-Hoffman, K., Levin, M., Ruskin, D., Wrobel, J., Park, D.W., Thomas, C., Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry 82 (2011), 667–680.
43. Stringham, J.M., Hammond, B.R., Macular pigment and visual performance under glare conditions. Optom. Vis. Sci. 85 (2008), 82–88.
44. Wenzel, A.J., Fuld, K., Stringham, J.M., J. Curran-Celentano J, Macular pigment optical density and photophobia light threshold. Vision Res. 46 (2006), 4615–4622.
45. Kvansakul, J., Rodriguez-Carmona, M., Edgar, D.F., Barker, F.M., Köpcke, W., Schalch, W., Barbur, J.L., Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol. Optic. 26 (2006), 362–371.
46. Johnson, E.J., Maras, J.E., Rasmussen, H.M., Tucker, K.L., Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. J. Am. Diet Assoc. 110:9 (2010), 1357–1362.
47. Nolan, J.M., Power, R., Stringham, J., Dennison, J., Stack, J., Kelly, D., Moran, R., Akuffo, K.O., Corcoran, L., Beatty S, S., Enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: central retinal enrichment supplementation trials - report 1. Invest. Ophthalmol. Vis. Sci. 57 (2016), 3429–3439.
48. Olmedilla, B., Granado, F., Blanco, I., Vaquero, M., Lutein, M., But not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 19 (2003), 21–24.
49. Wong, W.L., Su, X., Li, X., Cheung, C.M., Klein, R., Cheng, C.Y., Wong, T.Y., Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health, 2, 2014 e106–e116.
50. Liu, X.H., Yu, R.B., Liu, R., Hao, Z.X., Han, C.C., Zhu, Z.H., Ma, L., Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis. Nutrients 6 (2014), 452–465.
51. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol 131 (2013), 843–850.
52. Frost & Sullivan economic report, The economic benefits of using lutein and zeaxanthin food supplements in the european union. https://ww2.frost.com/files/7015/0772/2735/HCCS_Lutein_AMD.2017.10.12.pdf, 2017.
53. Biesalski, H.K., Erdman, J.W. Jr., Hathcock, J., Ellwood, K., Beatty, S., Johnson, E., Marchioli, R., Lauritzen, L., Rice, H.B., Shao, A., Griffiths, J.C., Nutrient reference values for bioactives: new approaches needed? A conference report. Eur. J. Nutr. 52:Suppl 1 (2013), 1–9.
54. Semba, R.D., Dagnelie, G., Are lutein and zeaxanthin conditionally essential nutrients for eye health?. Med. Hypotheses 61 (2003), 465–472.
55. Ranard, K.M., Jeon, S., Mohn, E.S., Griffiths, J.C., Johnson, E.J., Erdman, J.W. Jr., Dietary guidance for lutein: consideration for intake recommendations is scientifically supported. Eur. J. Nutr. 56:Suppl 3 (2017), S37–S42.
56. Keller, J.N., Schmitt, F.A., Scheff, S.W., Ding, Q., Chen, Q., Butterfield, D.A., Markesbery, W.R., Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 (2005), 1152–1156.
57. Hammond, B.R. Jr., Miller, L.S., Bello, M.O., Lindbergh, C.A., Mewborn, C., Renzi-Hammond, L.M., Effects of lutein/zeaxanthin supplementation on the cognitive function of community dwelling older adults: a randomized, double-masked, placebo-controlled trial. Front. Aging Neurosci., 9, 2017, 254, 10.3389/fnagi.2017.00254 eCollection 2017.
58. Unpublished data on file, DSM Nutritional Products.
59. Choi, H.D., Youn, Y.K., Shin, W.G., Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects, Plant Foods Hum. Nutrition 66 (2011), 363–369.
60. Miyawaki, H., Takahashi, J., Tsukahara, H., Takehara, I., Effects of astaxanthin on human blood rheology. J. Clin. Biochem. Nutr. 43 (2008), 69–74.
61. Nakagawa, K., Kiko, T., Miyazawa, T., Carpentero Burdeos, G., Kimura, F., Satoh, A., Miyazawa, T., Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br. J. Nutr. 105 (2011), 1563–1571.
62. Böhm, V., Lycopene and heart health. Mol. Nutr. Food Res. 56 (2012), 296–303.
63. Müller, L., Caris-Veyrat, C., Lowe, G., Böhm, V., Lycopene and its antioxidant role in the prevention of cardiovascular diseases-a critical review. Crit. Rev. Food Sci. Nutr. 56 (2016), 1868–1879.
64. Leermakers, E.T., Darweesh, S.K., Baena, C.P., Moreira, E.M., Melo van Lent, D., Tielemans, M.J., Muka, T., Vitezova, A., Chowdhury, R., Bramer, W.M., et al. The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis. Am. J. Clin. Nutr. 103 (2016), 481–494.
65. Yamaguchi, M., Uchiyama, S., Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: the unique anabolic effect of β-cryptoxanthin. Biol. Pharm. Bull. 26 (2003), 1188–1191.
66. Yamaguchi, M., Uchiyama, S., β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol. Cell. Biochem. 258 (2004), 137–144.
67. Yamaguchi, M., Igarashi, A., Uchiyama, S., Sugawara, K., Sumida, T., Morita, S., Ogawa, H., Nishitani, M., Kajimoto, Y., Effect of β-cryptoxanthin on circulating bone metabolic markers: intake of juice (Citrus unshiu) supplemented with β-cryptoxanthin has an effect in menopausal women. J. Health Sci. 52 (2006), 758–768.
68. Kim, D.E., Cho, S.H., Park, H.M., Chang, Y.K., Relationship between bone mineral density and dietary intake of beta-carotene, vitamin C, zinc and vegetables in postmenopausal Korean women: a cross-sectional study. J. Int. Med. Res. 44 (2016), 1103–1114.
69. Warnke, I., Goralczyk, R., Fuhrer, E., Schwager, J., Dietary constituents reduce lipid accumulation in murine C3H10 T1/2 adipocytes: a novel fluorescent method to quantify fat droplets. Nutr. Metab., 8(1), 2011, 30.
70. Bonet, M.L., Canas, J.A., Ribot, J., Palou, A., Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch. Biochem. Biophys. 572 (2015), 112–125.
71. Amengual, J., Gouranton, E., van Helden, Y.G.J., Hessel, S., Ribot, J., Kramer, E., Kiec-Wilk, B., Razny, U., Lietz, G., Wyss, A., Dembinska-Kiec, A., Palou, A., Keijer, J., Landrier, J.F., Bonet, M.L., von Lintig, J., Beta-carotene reduces body adiposity of mice via BCMO1. PLoS One, 6(6), 2011 e20644.
72. Canas, J.A., Lochrie, A., McGowan, A.G., Hossain, J., Schettino, C., Balagopal, P.B., Effects of mixed carotenoids on adipokines and abdominal adiposity in children, a pilot study. J. Clin. Endocrinol. Metab. 102 (2017), 1983–1990.
73. Clinton, S.K., Emenhiser, C., Schwartz, S.J., Bostwick, D.G., Williams, A.W., Moore, B.J., Erdman, J.W. Jr., Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biomark. Prev. 5 (1996), 823–833.
74. Zu, K., Mucci, L., Rosner, B.A., Clinton, S.K., Loda, M., Stampfer, M.J., Giovannucci, E., Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J. Natl. Cancer Inst., 106(2), 2014, 10.1093/jnci/djt430.
75. Rowles, J.L., Ranard, K.M., Smith, J.W., An, R., Erdman, J.W. Jr., Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 20:4 (2017), 361–377, 10.1038/pcan.2017.25.
76. Erhardt, A., Stahl, W., Sies, H., Lirussi, F., Donner, A., Häussinger, D., Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). Eur. J. Med. Res. 16 (2011), 76–78.
77. Ip, B.C., Liu, C., Ausman, L.M., von Lintig, J., Wang XD, X.D., Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice. Canc. Prev. Res. 7 (2014), 1219–1227 (Phila.).
78. Henriksen, B.S., Chan, G.M., Importance of carotenoids in optimizing eye and brain development. 59 J. Pediatr. Gastroenterol. Nutr., 59(5), 2014, 552, 10.1097/MPG.0000000000000471 Nov.
79. Hammond, B.R. Jr., Possible role for dietary lutein and zeaxanthin in visual development. Nutr. Rev. 66 (2008), 695–702.
80. Jackson, J.G., Lien, E.L., White, S.J., Bruns, N.J., Kuhlman, C.F., Major carotenoids in mature human milk: longitudinal and diurnal patterns. J. Nutr. Biochem. 9 (1998), 2–7.
81. Johnson, L., Norkus, E., Abbasi, S., et al. Contribution of beta-carotene (BC) from BC enriched formulae to individual and total serum carotenoids in term infants. [abstract] FASEB J, 9(4 Pt 3), 1995, 1869.
82. Bettler, J., Zimmer, J.P., Neuringer, M., DeRusso, P.A., Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur. J. Nutr. 49 (2010), 45–51.
83. Vishwanathan, R., Kuchan, M.J., Sen, S., Johnson, E.J., Lutein and preterm infants with decreased concentrations of brain carotenoids. J. Pediatr. Gastroenterol. Nutr. 59 (2014), 659–665.
84. Qiao, Y.L., Dawsey, S.M., Kamangar, F., Fan, J.H., Abnet, C.C., Sun, X.D., Johnson, L.L., Gail, M.H., Dong, Z.W., Yu, B., Mark, S.D., Taylor, P.R., Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the linxian general population nutrition intervention trial. J. Natl. Cancer Inst. 101 (2009), 507–518.
85. Kamangar F, F., Qiao, Y.L., Yu, B., Sun, X.D., Abnet, C.C., Fan, J.H., Mark, S.D., Zhao, P., Dawsey, S.M., Taylor, P.R., Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol. Biomark. Prev. 15 (2006), 1562–1564.
86. Blot, W.J., Li, J.Y., Taylor, P.R., Guo, W., Dawsey, S., Wang, G.Q., Yang, C.S., Zheng, S.F., Gail, M., Li, G.Y., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85 (1993), 1483–1492.
87. Hennekens, C.H., Buring, J.E., Manson, J.E., Stampfer, M., Rosner, B., Cook, N.R., Belanger, C., et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334 (1996), 1145–1149.
88. Cook, N.R., Le, I.M., Manson, J.E., Buring, J.E., Hennekens, C.H., Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 11 (2000), 617–626.
89. Albanes, D., Heinonen, O.P., Huttunen, J.K., Taylor, P.R., Virtamo, J., Edwards, B.K., Haapakoski, J., Rautalahti, M., Hartman, A.M., Palmgren, J., et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the alpha-tocopherol beta-carotene cancer prevention study. Am. J. Clin. Nutr., 62(6 Suppl), 1995 1427S-1430S.
90. Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L. Jr., Valanis, B., Williams, J.H. Jr., et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 88 (1996), 1550–1559.
91. Age-Related Eye Disease Study Research Group, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119 (2001), 1417–1436.
92. Mayne, S.T., Cartmel, B., Silva, F., Kim, C.S., Fallon, B.G., Briskin, K., Zheng, T., Baum, M., Shor-Posner, G., Goodwin, W.J. Jr., Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans. Am. J. Clin. Nutr. 68 (1998), 642–647.